Author: United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 212
Book Description
Comprehensive Final Report on State Regulatory Agencies & Professional Associations
Author: United States. Drug Enforcement Administration. Office of Compliance and Regulatory Affairs
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 212
Book Description
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 212
Book Description
Drug Enforcement Administration's Regulation of Medicine
Author: United States. Congress. House. Committee on the Judiciary. Subcommittee on Crime, Terrorism, and Homeland Security
Publisher:
ISBN:
Category : Political Science
Languages : en
Pages : 324
Book Description
Publisher:
ISBN:
Category : Political Science
Languages : en
Pages : 324
Book Description
Federal Regulation of Methadone Treatment
Author: Committee on Federal Regulation of Methadone Treatment
Publisher: National Academies Press
ISBN: 0309598621
Category : Medical
Languages : en
Pages : 251
Book Description
For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations.
Publisher: National Academies Press
ISBN: 0309598621
Category : Medical
Languages : en
Pages : 251
Book Description
For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations.
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Pharmacist's Manual
Code of Federal Regulations, Title 21: Parts 1300-End (Food and Drugs) Drug Enforcement Administration
Author:
Publisher:
ISBN: 9781630055608
Category :
Languages : en
Pages :
Book Description
Title 21 presents regulations promulgated by the Food and Drug Administration, the Drug Enforcement Administration, and the Office of the National Drug Control Agency in the area of food and drugs. These regulations encompass food and drugs for human and animal use, biologics, cosmetics, medical devices, radiological health, and controlled substances. Additions and revisions to this section of the code are posted annually by April. Publication follows within six months.
Publisher:
ISBN: 9781630055608
Category :
Languages : en
Pages :
Book Description
Title 21 presents regulations promulgated by the Food and Drug Administration, the Drug Enforcement Administration, and the Office of the National Drug Control Agency in the area of food and drugs. These regulations encompass food and drugs for human and animal use, biologics, cosmetics, medical devices, radiological health, and controlled substances. Additions and revisions to this section of the code are posted annually by April. Publication follows within six months.
Pharmacist's Manual
Author: United States. Drug Enforcement Administration
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 24
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 24
Book Description
Legal Issues Relating to the Disposal of Dispensed Controlled Substances
Author: Brian T. Yeh
Publisher: DIANE Publishing
ISBN: 1437941680
Category : Chemicals
Languages : en
Pages : 18
Book Description
Publisher: DIANE Publishing
ISBN: 1437941680
Category : Chemicals
Languages : en
Pages : 18
Book Description
Code of Federal Regulations, Title 21 Food and Drugs 170-199, Revised as of April 1, 2020
Author: Office Of The Federal Register (U.S.)
Publisher: Code of Federal Regulations, Title 21 Food and Drugs
ISBN: 9781641435758
Category :
Languages : en
Pages : 652
Book Description
Title 21 presents regulations promulgated by the Food and Drug Administration, the Drug Enforcement Administration, and the Office of the National Drug Control Agency in the area of food and drugs. These regulations encompass food and drugs for human and animal use, biologics, cosmetics, medical devices, radiological health, and controlled substances. Additions and revisions to this section of the code are posted annually by April. Publication follows within six months.
Publisher: Code of Federal Regulations, Title 21 Food and Drugs
ISBN: 9781641435758
Category :
Languages : en
Pages : 652
Book Description
Title 21 presents regulations promulgated by the Food and Drug Administration, the Drug Enforcement Administration, and the Office of the National Drug Control Agency in the area of food and drugs. These regulations encompass food and drugs for human and animal use, biologics, cosmetics, medical devices, radiological health, and controlled substances. Additions and revisions to this section of the code are posted annually by April. Publication follows within six months.
Code of Federal Regulations
Author:
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 192
Book Description
Special edition of the Federal register, containing a codification of documents of general applicability and future effect as of Apr. 1 ... with ancillaries.
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 192
Book Description
Special edition of the Federal register, containing a codification of documents of general applicability and future effect as of Apr. 1 ... with ancillaries.